Democrats’ drug pricing reforms aren’t what they seem

Forbes

19 October 2021 - As part of their spending bill, Congressional Democrats are advancing legislation that'll empower Medicare to "negotiate" drug prices in the program's Part B and Part D benefits. They insist this policy enjoys broad support among voters.

But they're misleading the public.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing